⌘K
Loading ticker…
As of 2026-08-25, Arvinas, Inc (ARVN) has a 3-month relative strength percentile of 63 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.5%, relative volume 0.57×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
ARVN is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 13.9% / -9.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
ARVN is held by 26 ETFs as of May 2026. Top owner: SCHA at 0.01% weight, $3M notional. Top 3 carry $7M.
Held by 55 ETFs · $79M across latest filings · largest weight 1.25% (XPH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $3M | — |
| VTWO | 0.01% | $3M | −0.01 pp |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| AVSC | 0.03% | $802K | — |
| CANC | 0.43% | $755K | +0.05 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.27% |
| $751K |
| −0.19 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $425K | — |
| ONEQ | 0.00% | $366K | new |
| VTWV | 0.03% | $355K | −0.02 pp |
| OASC | 0.18% | $152K | −0.11 pp |
Showing 10 of 26 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARVN Jan avg: 0.32% median: -1.69% win: 50% σ: 9.10% n: 4 2022-04-12 → 2026-07-31 | ARVN Feb avg: 1.00% median: -0.16% win: 50% σ: 7.20% n: 4 2022-04-12 → 2026-07-31 | ARVN Mar avg: -25.39% median: -15.49% win: 0% σ: 23.74% n: 4 2022-04-12 → 2026-07-31 | ARVN Apr avg: -2.74% median: -6.60% win: 20% σ: 23.54% n: 5 2022-04-12 → 2026-07-31 | ARVN May avg: -14.20% median: -16.71% win: 20% σ: 12.17% n: 5 2022-04-12 → 2026-07-31 | ARVN Jun avg: -2.05% median: 0.96% win: 60% σ: 12.40% n: 5 2022-04-12 → 2026-07-31 | ARVN Jul avg: 5.37% median: 1.09% win: 60% σ: 11.89% n: 5 2022-04-12 → 2026-07-31 | ARVN Aug avg: -1.79% median: -0.51% win: 50% σ: 14.57% n: 4 2022-04-12 → 2026-07-31 (current) | ARVN Sep avg: -5.23% median: -0.39% win: 50% σ: 18.05% n: 4 2022-04-12 → 2026-07-31 | ARVN Oct avg: 5.03% median: 9.52% win: 75% σ: 16.05% n: 4 2022-04-12 → 2026-07-31 | ARVN Nov avg: 11.02% median: 12.61% win: 75% σ: 23.93% n: 4 2022-04-12 → 2026-07-31 | ARVN Dec avg: 9.17% median: -11.20% win: 25% σ: 52.92% n: 4 2022-04-12 → 2026-07-31 |